Report on the joint EFPIA, DIA and EMEA pharmacogenetics workshop: moving toward clinical application

Author： McCarthy A Kerr M Abadie E Chibout S-D Imbert G Cohen N Drakoulis N Knudsen LE Flamion B Hashimoto L Kreutz W Verhoofstad G McHale D Mitchell T Papaluca Amati M Roberts R Shaw P Stuerzebecher CS Townend D

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.5, Iss.6, 2004-09, pp. : 731-739

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Joint EFPIA/CHMP SWP workshop: the Emerging Use of Omic Technologies for Regulatory Non-Clinical Safety Testing

By Kasper Peter Oliver Gerry Lima Beatriz Silva Singer Thomas Tweats David

Pharmacogenomics, Vol. 6, Iss. 2, 2005-03 ,pp. : 181-184

Future Medicine

Access to resources Recommend Favorite

DNA methylation biomarkers of cancer: moving toward clinical application

By Levenson Victor V

Pharmacogenomics, Vol. 5, Iss. 6, 2004-09 ,pp. : 699-707

Future Medicine

Access to resources Recommend Favorite

Fifth EMEA/IFAPP Conference. Meeting report: Clinical studies at the extremes of age

By Robert S.

International Journal of Pharmaceutical Medicine, Vol. 16, Iss. 1, 2002-02 ,pp. : 49-56

Adis International

Access to resources Recommend Favorite

Acceptability of Low Levels of Genotoxic Impurities in New Drug Substances: Conclusions of the Drug Information Association (DIA)/European Medicines Agency (EMEA) Workshop, October 27-28, 2003 in London, UK

By Peter Kasper

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 4, 2004-01 ,pp. : 221-223

Adis International

Access to resources Recommend Favorite

Neuropsychiatric pharmacogenetics: moving toward a comprehensive understanding of predicting risks and response

By Bishop Jeffrey R Ellingrod Vicki L

Pharmacogenomics, Vol. 5, Iss. 5, 2004-07 ,pp. : 463-477

Future Medicine

Access to resources Recommend Favorite